Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (TOPICAL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by University College, London.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Cancer Research UK
Roche Pharma AG
Information provided by (Responsible Party):
University College, London
ClinicalTrials.gov Identifier:
NCT00275132
First received: January 10, 2006
Last updated: December 9, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2012
  Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)